FDA Adverse Event
Malfunction
Summary report: N
CHLORAPREP ONE STEP HI- LITE ORANGE
MDR report key: 11844769
·
Received May 18, 2021
Report
- Report Number
- 3004932373-2021-00244
- Event Type
- Malfunction
- Date Received
- May 18, 2021
- Date of Event
- April 21, 2021
- Report Date
- May 18, 2021
- Manufacturer
- CAREFUSION 213, LLC 0113
- Product Code
- KXG
- PMA / PMN Number
- EXEMPT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
(B)(4) INITIAL EMDR SUBMISSION. A FOLLOW UP EMDR WILL BE SUBMITTED IF ADDITIONAL INFORMATION BECOMES AVAILABLE
Description of Event or Problem · 1
MATERIAL NO.: 930415. BATCH NO.: UNKNOWN. IT WAS REPORTED BY THE DISTRIBUTOR THAT THE PATIENT DEVELOPED POST OPERATIVE SKIN AND SOFT TISSUE INFECTION. PER MANUFACTURER NOTICE: THE DOCTOR REPORTS THAT A FEW DAYS AFTER A [OMITTED] PATIENT HAD A LAPAROSCOPIC TUBAL LIGATION PROCEDURE THE PATIENT DEVELOPED A SERIOUS POST OPERATIVE SKIN AND SOFT TISSUE INFECTION. THE PATIENT WAS TREATED WITH ANTIBIOTICS AND ALSO WENT TO THE HOSPITAL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 738207 | CHLORAPREP ONE STEP HI- LITE ORANGE | 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL | KXG | CAREFUSION 213, LLC 0113 | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 27 YR | Other |